A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitisHeiko Witt, Thomas Berg, Zoltán Kukor et al.|Nature Genetics|2006Cited by 250
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issuesPierre‐Régis Burgel, Peter G. Middleton, Kevin W Southern et al.|Journal of Cystic Fibrosis|2024Cited by 77
Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European UnionEnrico Costa, Hubert G. M. Leufkens, Silvia Girotti et al.|Journal of Cystic Fibrosis|2024Cited by 6